White Cells


  • Characterisation of leukaemia initiating mutations in CLL.
  • Development of a next generation sequencing CLL/lymphoid specific mutation panel for use in the NHS.
  • Development of a next generation sequencing myeloproliferative neoplasm panel to screen for variants in JAK2, MPL and Calreticulin genes.
  • Involvement in the 100,000 Cancer Genome Project (BRC pilot/IIP/main program).

© 2017 Oxford Molecular Diagnostic Centre. All rights reserved.

Last updated 23 Feb 2017.